Clinical Significance of CDFI-guided 125I Seed Implantation in The Treatment of Metastatic Superficial Tumor

doi:10.11748/bjmy.issn.1006-1703.2014.05.005

PDF(894 KB)

Labeled Immunoassays and Clinical Medicine ›› 2014, Vol. 21 ›› Issue (5) : 511. DOI: 10.11748/bjmy.issn.1006-1703.2014.05.005

Clinical Significance of CDFI-guided 125I Seed Implantation in The Treatment of Metastatic Superficial Tumor

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2014, 21(5): 511 https://doi.org/10.11748/bjmy.issn.1006-1703.2014.05.005

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(894 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2014-05-21	2014-07-16	2014-10-25
Issue Date
2014-11-06

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS